---
title: "Gold Mantis: Net profit for the third quarter was 23.6664 million yuan, a decrease of 80.87%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263285482.md"
description: "Gold Mantis announced that its revenue for the third quarter was 3.747 billion yuan, a decrease of 29.62%; net profit was 23.6664 million yuan, a decrease of 80.87%. Revenue for the first three quarters was 13.275 billion yuan, a decrease of 9.20%; net profit was 382 million yuan, a decrease of 18.47%"
datetime: "2025-10-29T12:14:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263285482.md)
  - [en](https://longbridge.com/en/news/263285482.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263285482.md)
---

# Gold Mantis: Net profit for the third quarter was 23.6664 million yuan, a decrease of 80.87%

Gold Mantis announced that its revenue for the third quarter was 3.747 billion yuan, a decrease of 29.62%; net profit was 23.6664 million yuan, a decrease of 80.87%. Revenue for the first three quarters was 13.275 billion yuan, a decrease of 9.20%; net profit was 382 million yuan, a decrease of 18.47%

### Related Stocks

- [002081.CN](https://longbridge.com/en/quote/002081.CN.md)

## Related News & Research

- [Canada's AirBoss Q2 revenue rises 9.4%](https://longbridge.com/en/news/295017359.md)
- [Chamath Palihapitiya backs harnesses and applications in AI investing guide](https://longbridge.com/en/news/294584636.md)
- [Poland - Factors to Watch August 3](https://longbridge.com/en/news/294649419.md)
- [11:31 ET/C O R R E C T I O N -- CENTEGIX/](https://longbridge.com/en/news/294988689.md)
- [Clarity Pharmaceuticals reports two additional complete responses in SECuRE trial 8 GBq 67Cu-SAR-bisPSMA cohort](https://longbridge.com/en/news/294972498.md)